Marçal Pastor Anglada-rekin lankidetzan egindako argitalpenak (8)

2008

  1. Compensatory effects of the human nucleoside transporters on the response to nucleoside-derived drugs in breast cancer MCF7 cells

    Biochemical Pharmacology, Vol. 75, Núm. 3, pp. 639-648

2005

  1. Cell entry and export of nucleoside analogues

    Virus Research, Vol. 107, Núm. 2, pp. 151-164

2004

  1. Electrophysiological Characterization of the Human Na +/Nucleoside Cotransporter 1 (hCNT1) and Role of Adenosine on hCNT1 Function

    Journal of Biological Chemistry, Vol. 279, Núm. 10, pp. 8999-9007

  2. Erratum: Electrophysiological characterization of the human Na +/nucleoside cotransporter 1 (hCNT1) and role of adenosine on hCNT1 function (The Journal of Biological Chemistry (2004) 279 (8999-9007))

    Journal of Biological Chemistry

  3. Interaction of nucleoside inhibitors of HIV-1 reverse transcriptase with the concentrative nucleoside transporter-1 (SLC28A1)

    Antiviral Therapy, Vol. 9, Núm. 6, pp. 993-1002

2002

  1. Nucleoside transporters in absorptive epithelia

    Journal of Physiology and Biochemistry

2001

  1. Role of the human concentrative nucleoside transporter (hCNT1) in the cytotoxic action of 5[prime]-deoxy-5-fluorouridine, an active intermediate metabolite of capecitabine, a novel oral anticancer drug

    Molecular Pharmacology, Vol. 59, Núm. 6, pp. 1542-1548

2000

  1. Electrogenic uptake of nucleosides and nucleoside-derived drugs by the human nucleoside transporter 1 (hCNT1) expressed in Xenopus laevis oocytes

    FEBS Letters, Vol. 481, Núm. 2, pp. 137-140